Sichuan Gowell Pharmaceutical Co., Ltd. was found in 2011, which is located in the Meishan New Economic Development District, Sichuan, China, has a registered capital of 50 million yuan and covers an area of nearly 30 acres.

It is a wholly-owned subsidiary of Chengdu Gowell Biopharmaceutical Co., Ltd.

It is a national high-tech enterprise specializing in the research, development, production and sales of high-end chemical generic medicine, OMEGA-3 fish oil unsaturated fatty acid series medicine and health foods, and peptide medicine.

The API and preparations are mainly concentrated in the cardiovascular system, urinary and renal system, digestive system and anti-infection system.

The company has established a provincial enterprise technology center and has achieved a number of scientific and technological achievements through independent innovation, external cooperation, resource introduction, etc.

At present, Sichuan Gowell has obtained 15 APIs, 10 pharmaceutical preparations and 3 health food production approvals, and has 4 domestic first-imitated products on the market, 5 national centralized procurement products, and 23 authorized patents, and it has obtained 1 national major new drug creation project and nearly 20 provincial, municipal and scientific and technological project supports.